S8. Enforcement status

No FDA enforcement action has stopped the seller from operating. Any warning letter naming the entity is disclosed on its record.

Most FDA warning letters concern marketing and labeling claims, not proof that a seller cannot lawfully trade. Treating every letter as a failure would tell a reader that a company under a labeling citation and a company shut down by a court are the same thing, and they are not. S8 records the letter in full and reserves the failing disposition for an action that ends the business. The method matters as much as the check: the index silently ignores server-side search terms, so only a local search with a positive control counts as performed.

Check method

The full FDA warning-letter index is downloaded and searched locally, with a known-positive control letter proving the search works. Hits are attributed by entity and address, never by name resemblance, then read to record what the letter alleges and whether the seller still operates.

What fails

An injunction, consent decree, seizure, or closure that halts the business fails S8. A warning letter alone does not: it is recorded and dated on the seller record instead.

Dispositions, all sellers

Seller	Disposition	Basis
Biotech Peptides	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Care Bare Rx	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Core Peptides	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
CoreAge Rx	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Direct Meds	PASS	FDA warning letter 716822, September 2025, names directmeds.com, Inc. over its online sale and labeling of compounded semaglutide and tirzepatide. No close-out letter appears in the index. No FDA action has halted the business, and the seller continues to operate.
Eden	PASS	FDA warning letter 728279, June 2026, names Eden Health International Inc. doing business as Eden at 110 16th St Ste 1431, Denver, Colorado, the address its own help page prints. It alleges that the pictured labels suggest Eden is the compounder when it is not, and that the site claimed its products come from FDA-licensed 503(a) outsourcing facilities. No close-out letter appears in the index. No FDA action has halted the business, and the seller still trades.
Found	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Gala Health	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
He & She MD	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
HealthRX	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Henry Meds	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Hims & Hers	PASS	FDA warning letter 716567 and FDA warning letter 716825, both September 2025, name Hims & Hers Health, Inc. doing business as Hims and as Hers at 2269 Chestnut St., #523, San Francisco, California, the address its own terms print. Each alleges that claims for its compounded semaglutide products, among them the same active ingredient as Ozempic and Wegovy, are false or misleading. No close-out letter appears in the index. No FDA action has halted the business, and the company continues to operate.
Ivim Health	PASS	FDA warning letter 721816, February 2026, names Ivim Services LLC doing business as Ivim at 4200 Regent Street, Suite 200, Columbus, Ohio, the address its own terms print. It alleges that the products pictured on the website identify Ivim on the label, suggesting Ivim is the compounder of those drugs when it is not. No close-out letter appears in the index. No FDA action has halted the business, and the seller still trades.
LifeMD	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Limitless Life Nootropics	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
MangoRx	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Mochi Health	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Oak	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Peptide Sciences	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Ro	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
SnagRx and Embody	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Sports Technology Labs	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.
Strut Health	PASS	FDA warning letter 721448, February 2026, names Strut Health, LLC dba Strut at 701 Commerce St, Dallas, Texas, alleging that claims about its compounded semaglutide and tirzepatide products, including the representation that Strut is the compounder, are false or misleading. No close-out letter appears in the index. No FDA action has halted the business, and the storefront still trades.
Swiss Chems	PASS	FDA warning letter 695663, December 2024, names Swisschems over unapproved semaglutide and retatrutide offered from this domain. No close-out letter appears in the index. No FDA action has halted the business, and the store still trades.
Synergy Rx	PASS	No letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.

Sellers satisfying S8 · every record below dated August 2026

Records above are dispositions, not endorsements. Some sellers are partners; each record disclaims its own links. Funding.

Part of the Standard, v1.1. Null semantics and re-check policy: method.